Total Payments
$105,537
2020 Payments
$9,100
Companies
3
Transactions
26
Payment Breakdown by Category
Consulting$103,356 (97.9%)
Travel$1,882 (1.8%)
Food & Beverage$298.98 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $103,356 | 18 | 97.9% |
| Travel and Lodging | $1,882 | 3 | 1.8% |
| Food and Beverage | $298.98 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $99,781 | 21 | $0 (2020) |
| Medicure Pharma Inc. | $3,500 | 4 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $2,256 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $9,100 | 4 | Janssen Scientific Affairs, LLC ($6,000) |
| 2019 | $34,000 | 4 | Janssen Scientific Affairs, LLC ($34,000) |
| 2018 | $25,200 | 4 | Janssen Scientific Affairs, LLC ($25,200) |
| 2017 | $37,237 | 14 | Janssen Scientific Affairs, LLC ($34,581) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2020 | Medicure Pharma Inc. | Acute cardiovascular care (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Aggrastat (tirofiban HCl) | ||||||
| 07/15/2020 | Medicure Pharma Inc. | Acute cardiovascular care (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Aggrastat (tirofiban HCl) | ||||||
| 03/06/2020 | Medicure Pharma Inc. | Acute cardiovascular care (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: Aggrastat (tirofiban HCl) | ||||||
| 02/20/2020 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $12,200.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/02/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $8,800.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/22/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $6,600.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $6,800.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $9,200.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/28/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2017 | Medicure Pharma Inc. | Aggrastat (tirofiban HCl) (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Acute cardiovascular care | ||||||
| 08/31/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/31/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $986.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/31/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/28/2017 | Regeneron Pharmaceuticals, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Consulting Fee | Cash or cash equivalent | $2,256.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/15/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $604.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $127.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2017 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $291.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
About Dr. Peter Berger, M.D
Dr. Peter Berger, M.D is a Cardiovascular Disease healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669489936.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Berger, M.D has received a total of $105,537 in payments from pharmaceutical and medical device companies, with $9,100 received in 2020. These payments were reported across 26 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($103,356).
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Danville, PA
- Active Since 08/01/2006
- Last Updated 12/08/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669489936
Products in Payments
- XARELTO (Drug) $99,781
- Acute cardiovascular care (Drug) $3,100
- PRALUENT ALIROCUMAB INJECTION (Biological) $2,256
- Aggrastat (tirofiban HCl) (Drug) $400.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Danville
George Ruiz, Md, MD
Cardiovascular Disease — Payments: $185,883
Cardiovascular Disease $185,883
Dr. Munveer Thind, M.d, M.D
Cardiovascular Disease — Payments: $61,338
Cardiovascular Disease $61,338
Sai Devarapalli, Md, MD
Cardiovascular Disease — Payments: $15,801
Cardiovascular Disease $15,801
Aslam Ahmad, Md, MD
Cardiovascular Disease — Payments: $7,269
Cardiovascular Disease $7,269
Dr. Andrew So, D.o, D.O
Cardiovascular Disease — Payments: $7,165
Cardiovascular Disease $7,165
Dr. Gary Miller, Md, MD
Cardiovascular Disease — Payments: $6,156
Cardiovascular Disease $6,156